Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Depression 2 Neoplasms 1 Neoplasm Metastasis 1 Hospice 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Emotional Regulation 1 Breast Neoplasms 1 Anxiety Disorders 1 Advanced Cancer 1

Interventions

Nivolumab 6 Ipilimumab 2 Gemcitabine 2 zaleplon 1 temsirolimus 1 relatlimab 1 regorafenib 1 olaparib 1 linrodostat 1 Vorinostat 1 Trastuzumab 1 Standard of Care 1 Sirolimus 1 Rehabilitation 1 Psychotherapy 1 Paclitaxel 1 Oxaliplatin 1 Niacin 1 IFL protocol 1 Health Services Needs and Demand 1 Everolimus 1 Clinical Trials, Phase IV as Topic 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Psychotherapy × 1 year × Clear all

NCT05398484 2025-12-04

Psilocybin Therapy in Advanced Cancer

NYU Langone Health

Phase 2/3 Recruiting

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡